Prevalence of Markers for Hepatitis A, B and C in the German Population. Results of the German National Health Interview and Examination Survey 1998

Overview

Journal Eur J Epidemiol

Specialty Public Health

Date 2002 Feb 22

PMID 11855576

Citations 20

Authors

W Thierfelder

W Hellenbrand

H Meisel

E Schreier

R Dortschy

Affiliations

Soon will be listed here.

Abstract

The prevalence of serological parameters indicative of infection with hepatitis A, B and C was determined using sera collected from representative population samples in the former East German (new) federal states and the West German (old) federal states during the German National Health and Examination Survey in 1998. Sera were tested for antibodies to hepatitis A virus (HAV), to hepatitis B core antigen (HBc) and to hepatitis B surface antigen (HBsAg), hepatitis C Virus (HCV), as well as for the presence of HBsAg and HCV-RNA. The mean weighted prevalence of anti-HAV was 46.5% (95% CI: 45.3-47.7) and increased markedly with age. The mean weighted prevalence of past infection with hepatitis B was 7.7% (95% CI: 7.0-8.4) in the old federal states and 4.3% (95% CI: 3.2-5.3) in the new federal states, corresponding to an overall prevalence of 7.0% (95% CI: 6.4-7.6). The mean weighted prevalence of HBsAg carriage was 0.6% (95% CI: 0.4-0.8), while the prevalence of HCV antibodies was 0.4% (95% CI: 0.2-0.5).

Citing Articles

Detection of Hepatitis C Virus Infection in Patients Undergoing Open Heart Surgery in Childhood Prior to 1992: A Danish Nationwide Cross-Sectional Study.

Rosendahl A, Uth L, Weis N, Smerup M, Ellesoe S Clin Med Insights Pediatr. 2025; 19:11795565251315722.

PMID: 39885994 PMC: 11776013. DOI: 10.1177/11795565251315722.

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B.

Sprinzl M, Feist C, Koch S, Kremer W, Lackner K, Weinmann A BMC Health Serv Res. 2021; 21(1):846.

PMID: 34419018 PMC: 8379870. DOI: 10.1186/s12913-021-06794-6.

Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.

Krumbholz A, Neubert A, Girschick H, Huppertz H, Kaiser P, Liese J Med Microbiol Immunol. 2013; 202(6):417-24.

PMID: 23812435 DOI: 10.1007/s00430-013-0303-4.

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Hahne S, Veldhuijzen I, Wiessing L, Lim T, Salminen M, van de Laar M BMC Infect Dis. 2013; 13:181.

PMID: 23597411 PMC: 3716892. DOI: 10.1186/1471-2334-13-181.

Is the HDV seroprevalence in patients admitted to a university hospital representative for all HBV carriers in Germany?.

Bissinger A, Berg C Infection. 2013; 41(5):1031-2.

PMID: 23435721 DOI: 10.1007/s15010-013-0433-z.

References

Beutels M, Van Damme P, Vranckx R, Meheus A . The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterol Belg. 1998; 61(1):4-7. View

Nothdurft H, Loscher T . [Sequelae of imported tropical diseases in Germany]. Versicherungsmedizin. 1994; 46(4):135-7. View

Studer S, Joller-Jemelka H, Steffen R, Grob P . Prevalence of hepatitis A antibodies in Swiss travellers. Eur J Epidemiol. 1993; 9(1):50-4. DOI: 10.1007/BF00463089. View

Prodinger W, Larcher C, Solder B, Geissler D, Dierich M . Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation. Infection. 1994; 22(1):53-5. DOI: 10.1007/BF01780769. View

Weber B, Rabenau H, Berger A, Scheuermann E, Staszewski S, Kreuz W . Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups/Frankfurt a.M., Germany. Zentralbl Bakteriol. 1995; 282(1):102-12. DOI: 10.1016/s0934-8840(11)80802-9. View

Bellach B, Knopf H, Thefeld W . [The German Health Survey. 1997/98]. Gesundheitswesen. 1999; 60 Suppl 2:S59-68. View

Hillemanns P, Langenegger P, Langer B, Knitza R, Hasbargen U, Hepp H . [Prevalence and follow-up of hepatitis C virus infection in pregnancy]. Z Geburtshilfe Neonatol. 1998; 202(3):127-30. View

Stark K, Schreier E, Muller R, Wirth D, Driesel G, Bienzle U . Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis. 1995; 27(4):331-7. DOI: 10.3109/00365549509032726. View

Koerner K, Cardoso M, Dengler T, Kerowgan M, Kubanek B . Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang. 1998; 74(4):213-6. View

10.

Neifer S, Molz B, Sucker U, Kreuzpaintner E, Weinberger K, Jilg W . [High percentage of isolated anti-HBc-positive persons among prisoners]. Gesundheitswesen. 1997; 59(6):409-12. View

11.

Resina Robert A, Fahim Zawati Z, Dominguez Grandal C . [Prevalence of serological markers of the hepatitis B virus in the out-patient population of the city of Vigo]. Aten Primaria. 1992; 10(9):1028-9. View

12.

Garcia-Fulgueiras A, Tormo M, Rodriguez T, Perez-Flores D, Chirlaque D, Navarro C . Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis. 1996; 28(1):17-20. DOI: 10.3109/00365549609027143. View

13.

Schenzle D, Dietz K, Frosner G . Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys. Am J Epidemiol. 1979; 110(1):70-6. DOI: 10.1093/oxfordjournals.aje.a112790. View

14.

Thefeld W, Stolzenberg H, Bellach B . [The Federal Health Survey: response, composition of participants and non-responder analysis]. Gesundheitswesen. 2000; 61 Spec No:S57-61. View

15.

Christenson B, BOTTIGER M, Grillner L . The prevalence of hepatitis B in Sweden; a statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect. 1997; 119(2):221-5. PMC: 2808843. DOI: 10.1017/s0950268897007838. View

16.

Hofmann F, Wehrle G, Berthold H, Koster D . Hepatitis A as an occupational hazard. Vaccine. 1992; 10 Suppl 1:S82-4. DOI: 10.1016/0264-410x(92)90552-u. View

17.

Hart G . Factors associated with hepatitis B infection. Int J STD AIDS. 1993; 4(2):102-6. DOI: 10.1177/095646249300400209. View

18.

Joller-Jemelka H, Wicki A, Grob P . Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol. 1994; 21(2):269-72. DOI: 10.1016/s0168-8278(05)80407-6. View

19.

Abb J . [Prevalence of hepatitis A virus antibodies in hospital personnel]. Gesundheitswesen. 1994; 56(7):377-9. View

20.

Palitzsch K, Hottentrager B, Schlottmann K, Frick E, Holstege A, Scholmerich J . Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol. 1999; 11(11):1215-20. DOI: 10.1097/00042737-199911000-00005. View